Compare BLCO & CIGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BLCO | CIGI |
|---|---|---|
| Founded | 1853 | 1972 |
| Country | Canada | Canada |
| Employees | N/A | N/A |
| Industry | Ophthalmic Goods | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 5.8B |
| IPO Year | 2022 | 1995 |
| Metric | BLCO | CIGI |
|---|---|---|
| Price | $16.32 | $104.12 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 5 |
| Target Price | $18.45 | ★ $176.25 |
| AVG Volume (30 Days) | ★ 358.5K | 144.9K |
| Earning Date | 04-29-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 0.29% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $5,101,000,000.00 | N/A |
| Revenue This Year | $8.65 | $17.28 |
| Revenue Next Year | $5.59 | $8.30 |
| P/E Ratio | ★ N/A | $57.57 |
| Revenue Growth | ★ 6.47 | N/A |
| 52 Week Low | $10.83 | $95.66 |
| 52 Week High | $18.92 | $171.20 |
| Indicator | BLCO | CIGI |
|---|---|---|
| Relative Strength Index (RSI) | 51.18 | 37.71 |
| Support Level | $16.26 | $97.32 |
| Resistance Level | $17.11 | $120.37 |
| Average True Range (ATR) | 0.47 | 3.26 |
| MACD | -0.02 | -0.99 |
| Stochastic Oscillator | 56.18 | 9.24 |
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
Colliers International Group Inc provides commercial real estate professional services and investment management to corporate and institutional clients across different countries around the world. Its operating segments are Commercial Real Estate, Engineering and Investment Management. Maximum revenue for the company is generated from its Commercial Real Estate segment, which offers services like transaction and debt finance services, outsourcing in property management, valuation and advisory, loan servicing, and others. Geographically, the company generates maximum revenue from the United States followed by Canada, Euro currency countries, Australia, the United Kingdom, Poland, China, India, and other regions.